Hijazi et al. reported that the levels of NT-proBNP, hs-cTnT, and D-dimer can significantly predict the risk of stroke/systemic embolic events, major bleeding, and mortality within 12 months following a diagnosis of AF [27]. This evidence concerns the gene TNNT2 and stroke disorder.